Project
5-Azacytidine to treat acute myeloid leukemia in elderly or frail patients not suitable for intensive chemotherapy. A multicenter phase II trial
Automatically Closed · 2009 until 2012
Hess Urs
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2009
End Date
2012
Financing
Others
Study Design
Multicenter phase II trial.
Keywords
AML, 5-azacytidine
Partner
Celgene, Prof. Dr. med. Jakob Passweg, Hôpital Universitaire de Genève, Dr. med. Sabine Blum, CHUV, Lausanne
Brief description/objective
To evaluate the efficacy of 5-azacytidine in a population of patients with AML not suitable for induction type chemotherapy because of age or relevant comorbidities.